Nucleic acid sequence amplification is a reaction where the nucleic acid sequence is amplified in quantity. An isothermal reaction is a reaction where there is limited change in temperature. Numerous isothermal amplification techniques have been developed to enable rapid and sensitive detection of nucleic acid sequences without the need for precise temperature cycling as required in conventional polymerase chain reaction (PCR), making it possible to implement low-cost molecular diagnostics for point-of-care and field-deployable applications. State-of-the-art isothermal amplification protocols include loop-mediated isothermal amplification (LAMP), which includes as a subset reverse-transcription LAMP (RT-LAMP).
Additional “LAMP-like” isothermal amplification reactions include other variations of isothermal nucleic acid amplification protocols, such as using dual-priming, swarm priming, stem priming, hairpin primers, etcetera. In general, LAMP and LAMP-like isothermal amplification reactions are prone to false positives partly due to the simultaneous use of multiple primers for target recognition, which increases the likelihood of primer-primer interactions and formation of primer secondary structures leading to non-specific amplification in absence of the target sequence.1
Nucleic acid hybridization is a technique in which single-stranded nucleic acid sequence and a complementary nucleic acid sequence interact to form a nucleic acid complex. In PCR and LAMP protocols, partial hybridization between the primers and non-target sequences can also lead to spurious amplification. Despite meticulous primer design and in silico optimization efforts, there is still a lack of a universal metric to predict the performance of primers during actual amplification.2 As a result, time-consuming experimental screening and manual adjustment of multiple candidate primer sets are typically unavoidable in practice, making the already sophisticated assay design and optimization process even more challenging and tedious.
To improve the assay reliability, prior approaches have made use of chemical or enzymatic additives to delay or prevent the generation of nonspecific amplicons;3 however, these techniques not only increase the cost of the assay but also alter and complicate the overall reaction condition. Other techniques for enhancing the signal-to-noise ratio of isothermal amplification rely on the use of sequence-specific reporter probes or similar constructs to detect the target amplicon.4-8 However, these techniques only distinguish the target amplicon from a resultant pool of amplification products, and cannot prevent the exponential generation of nonspecific amplicons starting from the initial stages of the reaction, and as a result, the assay readout must rely on target-specific detection (e.g., fluorescence-quencher probes). Such methods thus cannot allow the use of more convenient and potentially lower-cost methods (e.g., pH-based colorimetric change, turbidity, intercalating dyes) that directly probe the total DNA synthesis during the amplification. These drawbacks limit the general use of such enhancement techniques in point-of-care assays, which require quick visual interpretation of the test result without reliance on specialized readout devices.
Accordingly, there is an ongoing need for a simple, efficient, and programmable approach for assay specificity enhancement that can be generally applied to different molecular detection, transduction, amplification, and readout protocols.
Disclosed herein are compositions and methods directed to novel molecular mechanisms that leverage programmable, competitive hybridization and strand displacement of nucleic acids to effectively suppress the generation of nonspecific reaction products (i.e., false positives) in molecular detection, transduction, and isothermal amplification of DNA or RNA targets. Specifically, the present disclosure proposes a general framework of several molecular mechanisms referred to herein as “armoring/de-armoring”, “thresholding/de-thresholding”, and “deactivating/reactivating”. These molecular mechanisms make use of short single-stranded nucleic acid oligonucleotides (i.e., “oligos”) or pre-annealed oligo dimers that have programmable interactions with the primers, the target sequence, or the transduced strand of the target sequence to control or moderate the initiation and progress of further reactions in different molecular protocols.
Strand displacement is a reaction in a nucleic acid complex that exchanges one nucleic acid strand with another replacement strand. The proposed molecular mechanisms can be designed, modularized, and implemented in vitro based on the well-characterized principles of nucleic acid hybridization and strand displacement.9-12 By programming the thermodynamic and kinetic parameters of hybridization and strand displacement, these molecular mechanisms can be custom-programmed and incorporated into different molecular detection, transduction, amplification, and readout pathways to reliably improve the specificity for detecting trace amounts of the target DNA or RNA molecule without sacrificing overall reaction speed and sensitivity.
A reaction cascade is a series of reactions. Nucleic acid strand transduction is a reaction where one input nucleic acid strand is replaced with another output nucleic acid strand. Thresholded transduction is transduction predicated on a threshold quantity of the input nucleic acid strand. A reaction such as amplification or transduction is armored if it is not able to occur without appropriate initiation. The designs disclosed herein enable the construction of effective nucleic acid reaction cascades including but not limited to (1) armored amplification (
It is to be understood that the molecular mechanisms disclosed herein (including armoring, de-armoring, thresholding, de-thresholding, deactivating, reactivating) are not limited to the example designs of nucleic acid modules described herein. For example, the basic nucleic acid components of the disclosed reaction protocols (e.g., the armor strand, threshold complex, deactivation strand, etc.) can be designed and optimized according to requirements of the intended assay with flexible choice of the hybridization site, length, stability, use of mismatched bases, toehold, and variants or modifications of nucleic acid sequences, for example. In some embodiments, for example, the nucleic acid modules may be designed to leverage DNA hairpins16 instead of the basic duplex-form constructs. Some embodiments may leverage the use of nucleic acid analogues such as PNA and LNA17-19 in place of or in combination with DNA and/or RNA to achieve desired thermodynamic properties of the molecular mechanism.
It is also to be understood that the applications of the disclosed molecular mechanisms are not limited to specific methods or implementations of molecular detection, transduction, amplification, and/or readout systems unless otherwise specified. For example, the disclosed molecular mechanisms can be utilized to enhance the detection of nucleic acid targets including but are not limited to DNA, dsDNA, ssDNA, RNA, mRNA, microRNA, tRNA, rRNA, sgRNA, siRNA, and analogs of the foregoing such as PNA, LNA, TNA, HNA, GNA, and the like.
In some embodiments, the disclosed molecular mechanisms may be leveraged to improve the specificity of various isothermal amplification techniques other than the conventional LAMP and/or RT-LAMP methods, for example, including but not limited to variations of LAMP-like amplification techniques based on dual-priming, swarm priming, stem priming, hairpin primers, etcetera.20-25 Some of the underlying mechanisms proposed herein (e.g., armoring and un-armoring) may also be strategically utilized to enhance the performance of conventional thermocycling-based amplification methods such as PCR, RT-PCR, qPCR, and RT-qPCR.
This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an indication of the scope of the claimed subject matter.
Various objects, features, characteristics, and advantages of the invention will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings and the appended claims, all of which form a part of this specification.
The present disclosure describes nucleic-acid-based molecular mechanisms that may be utilized to address the non-specific amplification (false positive) limitations associated with conventional isothermal amplification protocols such as LAMP and RT-LAMP. The underlying principles can also be custom-programmed and broadly applied to enhance the specificity and signal-to-noise ratio of other molecular detection, transduction, amplification, and readout protocols.
In some embodiments, armoring can be achieved by the introduction of a short single-stranded nucleic acid “armor strand” that contains a subsequence of sufficient length complementary to the 3′ segment of a primer used in a nucleic acid detection, transduction, or amplification protocol. The 3′ end of the armor strand is designed to deter polymerase extension (for example, by appending a short overhang “toehold”, incorporating a modification such as 3′ inverted dT, 3′ ddC, 3′ C3 spacer, 3′ amino, or 3′ phosphorylation that blocks extension by DNA polymerase, incorporating nonstandard nucleic acid bases, or G quadruplex).
During the reaction of an assay, the armor strand is present in the solution at moderately high concentration such that its competitive binding to the primer enforces a higher energy threshold for the occurrence of complete primer binding to the priming site on the target sequence, thereby increasing the stringency for the onset of target-specific amplification. In some embodiments, a “moderately high concentration” for the armor strand can be a concentration that is 0.05×, 0.1×, 0.2×, 0.3×, 0.4×, 0.5×, 0.6×, 0.7×, 0.8×, 0.9×, 1.0×, 1.1×, 1.2×, 1.3×, 1.4×, 1.5×, 1.6×, 1.7×, 1.8×, 1.9×, or 2.0× the concentration of the corresponding primer to which it binds, or can be within a range using any combination of the foregoing as endpoints.
With appropriately adjusted concentration and thermodynamic parameters of the armor strand, the hybridization between the armor strand and the primer can help to block or at least transiently sequester the 3′ end of the primer to effectively inhibit spurious primer-primer and primer-template interactions to reduce false positives. Further, once a primer is armored (i.e., bound with its armor strand), it must undergo an initial partial binding to the target priming site then followed by branch migration and strand displacement to release the initially bound armor strand (i.e., de-armoring) before the primer can fully hybridize to its target sequence and initialize polymerase extension.
In some embodiments, the binding site and sequences of the primer and armor strand can be adjusted and optimized to discriminate single nucleotide mutations on the target DNA or RNA owing to the high specificity driven by thermodynamic properties of nucleic acid strand displacement reactions. The extent of armoring can be controlled by adjusting the initial concentration of the armor strand in solution. In some embodiments, de-armoring refers to the reduction in armor strand concentration or the absence of armor strand in reaction. Furthermore, depending on the implementation and performance requirements of the assay, some embodiments can leverage one or more armored primers in a one-pot reaction.
In some embodiments, thresholding can be achieved by the introduction of a pre-annealed oligo dimer termed a “threshold complex”, which is designed to consume an input strand up to a pre-determined threshold level before the input strand can effectively trigger any downstream reactions. In some embodiments, the input to the threshold complex can be a target-transduced strand (released from an upstream transduction protocol) that functions as a primer for a downstream amplification protocol. The thresholding mechanism is designed to suppress potential background leakage (i.e., unintended triggering of downstream reactions due to spurious exposure of binding domains from upstream reaction components) that may occur in cascaded reaction pathways of an assay, caused by factors such as mis-formed or non-annealed nucleic acid complexes.
The input strand (which functions as the “primer” for a downstream amplification protocol) consumed by thresholding is rendered in the form of an inert waste species that in some embodiments can be simply a blunt-ended duplex. Reaction between the primer and the threshold complex also results in the release of a single-stranded nucleic acid oligo called “moderator strand” from the threshold complex. Because the moderator strand contains a subsequence identical to the 5′ segment of the primer sequence, the moderator strand (once freed from the threshold complex) can compete with the primer in binding with the downstream amplification priming site. Such a competitive binding may also be designed to limit initiation of false amplification by inclusion of a 3′ modification (e.g., short overhang toehold, 3′ inverted dT, 3′ ddC, 3′ C3 spacer, 3′ amino, 3′ phosphorylation, nonstandard nucleic acid bases, or G quadruplex) on the moderator strand that prevents polymerase extension. These molecular mechanisms decrease leakage and increase specificity simultaneously.
The extent of thresholding can be controlled by adjusting the initial concentration of the threshold complex in solution. In some embodiments, de-thresholding refers to the reduction in threshold complex concentration or the absence of threshold complex in reaction. Furthermore, depending on the implementation and performance requirements of the assay, some embodiments can leverage threshold complexes for one or more primers or transduced strands in a one-pot reaction.
In some embodiments, the thresholding mechanism may be combined with the armoring mechanism in a single assay and/or reaction mixture.
In some embodiments, a primer for a downstream amplification protocol is initially deactivated by annealing to a deactivation strand to form a “deactivated primer” dimer including a hybridized domain of sufficient length that it fully sequesters the primer at its 3′ end. This pre-annealed dimer has an extended overhang at the 3′ end of the deactivation strand. In some embodiments, the transduced strand released from an upstream detection and transduction protocol are designed to function as a “reactivation strand”, which recognizes the exposed overhang of the deactivated primer and triggers strand displacement to release the initially bound primer from the deactivated primer dimer. Because the reactivation strand contains a subsequence identical to the 3′ segment of the primer sequence, the reactivation strand (once released from the upstream detection or transduction protocol) can compete with the primer in binding with the downstream amplification priming site. Such a competitive binding may also be designed to limit initiation of false amplification by way of a 3′ modification (e.g., short overhang toehold, 3′ inverted dT, 3′ ddC, 3′ C3 spacer, 3′ amino, or 3′ phosphorylation, nonstandard nucleic acid bases, or G quadruplex) on the reactivation strand that prevents polymerase extension.
In some embodiments, the deactivated primer mechanism can be used in tandem with the armoring and/or thresholding mechanism to offer another layer of protection against the generation of false positive amplicons in molecular assays. Furthermore, depending on the implementation and performance requirements of the assay, some embodiments can leverage one or more deactivated primers in a one-pot reaction.
In the illustrations and accompanying descriptions disclosed below, an asterisk (*) denotes sequence reverse complementarity. For example, the complementary sequence of oligo a is denoted by a*.
In
Some of the armor strands are initially unbound and free in solution at moderately high concentration. Hybridization between the primer and a free armor strand forms an armored primer that leaves the 5′ subsequence (i.e., domain a) of the primer exposed and free to bind with the target DNA or RNA via the corresponding subsequence (i.e., domain a*) of the priming site.
In
Components (B) are the set of LAMP primers designed for isothermal amplification of the target. Specifically, the set comprises the F3 primer, the B3 primer, the LoopF primer, the LoopB primer, with the armored FIP primer and the armored BIP primer. The armored FIP primer is formed by a primer nucleic acid strand consisting of subsequences F1* and F2 (listed from the 5′ to 3′ orientation) and an armor strand that hybridizes to the F2.2 subdomain of the F2 subsequence on the primer nucleic acid strand. The armor strand contains a simple 3′ modification such as a short overhang toehold, an inverted dT, or other 3′ modification as disclosed herein to prevent polymerase extension.
Similarly, the armored BIP primer is formed by a primer nucleic acid strand consisting of subsequences B1* and B2 (listed from the 5′ to 3′ orientation) and an armor strand that hybridizes to the B2.2 subdomain of the B2 subsequence on the primer nucleic acid strand. The armor strand contains a simple 3′ modification such as a short overhang toehold, an inverted dT, or other 3′ modification disclosed herein to prevent polymerase extension. In some embodiments, other essential primers (e.g., F3 primer and/or B3 primer) from the LAMP primer set can be armored in a similar fashion. Component C indicates that the reaction contains a strand-displacing polymerase such as Bst 2.0. Component D indicates that the reaction may also contain a reverse transcriptase if the amplification target is RNA sequence.
In
Steps (3-10) illustrate a series of primer extension and strand-displacing polymerization reactions of LAMP that leads to the formation of the basic dumbbell DNA structure that serves as the starting material for self-primed auto-cycling amplification reaction of LAMP. Specifically, Steps (3-5) indicate the processes including the primer extension from the 3′ end of the fully hybridized FIP primer on target, followed by binding of the F3 primer on the target that primes strand-displacing polymerization to release the newly synthesized strand primed by FIP. Step (6) illustrates that the armored BIP primer hybridizes to the B2.1* subsequence of the B2* priming site on the newly formed DNA structure from the previous step. Step (7) indicates the process of branch migration and strand displacement resulting in full hybridization between the B2 subsequence of the BIP primer and the B2* subsequence of the newly formed DNA structure. At the same time, the armor strand is released from the armored BIP primer and become free to armor another unbound BIP primer in the solution. Steps (8-10) indicates the processes including the primer extension from the 3′ end of the fully hybridized BIP primer, followed by binding of the B3 primer to the priming site B3*, which primes strand-displacing polymerization to release the newly synthesized strand primed by BIP and result in the formation of the basic dumbbell DNA structures.
Steps (11-13) indicate the initialization of the LAMP auto-cycling amplification. These downstream reactions involve the participation of the armored FIP primer, the armored BIP primer, and the loop primers LoopF and LoopB. Note that the effect of armoring on FIP and BIP is also present in these reactions, which helps to maintain specificity during exponential amplification. For brevity, detailed illustrations for the hybridization, strand displacement, and strand-displacing polymerization reactions involved in these processes, which are known in the art, are not shown.
In
Component (A) illustrates that the target DNA or RNA sequence contain three adjacent hybridization sites recognized by the transduction protocol, including P2, P1, and P3 (listed from the 3′ to 5′ orientation). Component (B) illustrates an armored scheme for the loaded primer A, consisting of a primer with subsequence U* and P1* (listed from the 3′ to 5′ orientation) hybridized to a transduction strand U on the 5′ end and an armor strand on the 3′ end, respectively. The armor strand contains a simple 3′ modification (as indicated by the letter tin the drawing) such as a short overhang toehold or an inverted dT to prevent polymerase extension. The armor strand is initially unbound and free in solution at moderately high concentration. Hybridization between the loaded primer A and the armor strand forms an armored primer that leaves the P1.1* subsequence of the primer exposed and free to bind with the target DNA or RNA.
Component (C) illustrates a primer B consisting of nucleic acid sequence P2*. Component (D) illustrates a primer C consisting of nucleic acid sequence P3. In some embodiments, the primer B and/or primer C may be armored in a similar fashion described above. Component (E) indicates that the reaction contains a strand-displacing polymerase such as Bst 2.0. Component (F) indicates that the reaction may also contain a reverse transcriptase if the transduction target is RNA sequence.
In
In
In
In
During thresholding, the transduced strand U binds to the exposed U.1* domain on the threshold complex, and via strand displacement, releases the moderator strand from the threshold complex and at the same time, consumes the single-stranded transduced U into the formation of a blunt-ended duplex that is functionally inert and can be viewed as a waste species in the solution. In some embodiments, the threshold level can be simply adjusted by varying the concentration of the threshold complex.
Step (C1) illustrates that the moderator strand released from the thresholding reaction can compete with the transduced strand U (which functions as an essential primer for a downstream amplification protocol) in binding with the target priming site. The competitive binding of moderator strand, however, does not trigger false amplification owing to the presence of its 3′ modification that deters polymerase extension.
Step (C2) illustrates that after thresholding, the remaining transduced strands U from the solution can fully hybridize to the target priming site and trigger the downstream amplification. Such an initialization of the amplification protocol is only effective if the total amount of U released from the upstream transduction protocol sufficiently exceeds the threshold level set by the thresholding reaction.
In
Step (B) illustrates that the presence of a target DNA or RNA sequence is detected by a transduction protocol (such as disclosed herein) and results in the release of a transduced strand which functions as a “reactivation strand” in the following reactions. For example, the reactivation strand consists of subsequences e, b, and t listed from the 5′ to 3′ orientation, and through the binding of subsequence e of the reactivation strand to the extended 3′ overhang sequence e* of the deactivated primer, strand displacement reaction can proceed and lead to the release of the primer from the deactivated primer dimer. This released primer is now considered reactivated and is free to hybridize to its target priming site (i.e., a* b*) on a downstream amplification template, which, in some embodiments, can be a universal template for a highly optimized amplification protocol. The reactivation reaction also generates an inert duplex that is functionally considered a waste species. Step (C) illustrates that the reactivated primer fully hybridizes to the target template to initiate the downstream amplification protocol.
While certain embodiments of the present disclosure have been described in detail, with reference to specific configurations, parameters, components, elements, etcetera, the descriptions are illustrative and are not to be construed as limiting the scope of the claimed invention.
Furthermore, it should be understood that for any given element of component of a described embodiment, any of the possible alternatives listed for that element or component may generally be used individually or in combination with one another, unless implicitly or explicitly stated otherwise.
In addition, numbers expressing quantities, constituents, distances, or other measurements used in the specification and claims may optionally be modified by the term “about” or its synonyms. When the terms “about,” “approximately,” “substantially,” or the like are used in conjunction with a stated amount, value, or condition, it may be taken to mean an amount, value or condition that deviates by less than 20%, less than 10%, less than 5%, less than 1%, less than 0.1%, or less than 0.01% of the stated amount, value, or condition.
The embodiments disclosed herein should be understood as comprising/including disclosed components, and may therefore include additional components not specifically described. Optionally, the embodiments disclosed herein are essentially free or completely free of components that are not specifically described. That is, non-disclosed components may optionally be completely omitted or essentially omitted from the disclosed embodiments. For example, amplification reaction mixture components not specifically disclosed and/or not necessarily required to carry out the disclosed methods may be completely omitted or essentially omitted from the disclosed embodiments.
An embodiment that “essentially omits” or is “essentially free of” a component may include trace amounts and/or non-functional amounts of the component. For example, an “essentially omitted” component may be included in an amount no more than 2.5%, no more than 1%, no more than 0.1%, or no more than 0.01% by total weight or total volume of the reaction mixture. This is likewise applicable to other negative modifier phrases such as “essentially omits,” “essentially without,” similar phrases using “substantially” or other synonyms of “essentially.”
Any headings and subheadings used herein are for organizational purposes only and are not meant to be used to limit the scope of the description or the claims. References provided herein are incorporated herein by reference.
It will also be noted that, as used in this specification and the appended claims, the singular forms “a,” “an” and “the” do not exclude plural referents unless the context clearly dictates otherwise.
It will also be appreciated that embodiments described herein may also include properties and/or features (e.g., ingredients, components, members, elements, parts, and/or portions) described in one or more separate embodiments and are not necessarily limited strictly to the features expressly described for that particular embodiment. Accordingly, the various features of a given embodiment can be combined with and/or incorporated into other embodiments of the present disclosure. Thus, disclosure of certain features relative to a specific embodiment of the present disclosure should not be construed as limiting application or inclusion of said features to the specific embodiment. Rather, it will be appreciated that other embodiments can also include such features.
This Application claims priority to and the benefit of U.S. Provisional Patent Application No. 63/315,635, filed Mar. 2, 2022, which is incorporated herein by this reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63315635 | Mar 2022 | US |